SMC announced that Phenex Pharmaceuticals AG presented results of a study using STAM™ model at oral presentation at EASL the International Liver CongressTM 2019 in Vienna, Austria, April 10-19, 2019.

Title: LXR inverse agonists reduce steatosis and fibrosis in the STAM™ mouse model but also improve insulin sensitivity in a high fat diet mouse clamp study